Cardiovascular Ultrasound
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
 ResearchEarly right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography studySebastian Schattke1* , Fabian Knebel1* , Andrea Grohmann1 , Henryk Dreger1 , Friederike Kmezik1 , Gabriela Riemekasten2 , Gert Baumann1 and Adrian C Borges1  1
Universitätsmedizin Berlin, Medical Clinic for Cardiology and Angiology, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany 2
Universitätsmedizin Berlin, Medical Clinic for Rheumatology, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany author email corresponding author email* Contributed equally
Cardiovascular Ultrasound 2010,
8:3doi:10.1186/1476-7120-8-3
|
| Published: |
22 January 2010 |
Abstract
Background
Isovolumetric acceleration (IVA) is a novel tissue Doppler parameter for the assessment of systolic function. The aim of this study was to evaluate IVA as an early parameter for the detection of right ventricular (RV) systolic dysfunction in patients with systemic sclerosis (SSc) without pulmonary hypertension.
Methods
22 patients and 22 gender- and age-matched healthy subjects underwent standard echocardiography with tissue Doppler imaging (TDI) and speckle tracking strain to assess RV function.
Results
Tricuspid annular plane systolic excursion (TAPSE) (23.2 ± 4.1 mm vs. 26.5 ± 2.9 mm, p < 0.006), peak myocardial systolic velocity (Sm) (11.6 ± 2.3 cm/s vs. 13.9 ± 2.7 cm/s, p = 0.005), isovolumetric contraction velocity (IVV) (10.3 ± 3 cm/s vs. 14.8 ± 3 cm/s, p < 0.001) and IVA (2.3 ± 0.4 m/s2 vs. 4.1 ± 0.8 m/s2, p < 0.001) were significant lower in the patient group. IVA was the best parameter to predict early systolic dysfunction with an area under the curve of 0.988.
Conclusion
IVA is a useful tool with high-predictive power to detect early right ventricular systolic impairment in patients with SSc and without pulmonary hypertension. |